We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review

Published: July 2019
Pages: 53
Code: 00A3E0A936A5D1FB69ED30DBB8042578
Format: PDF
Publisher GlobalData
From Add to basket
$ 125.00
Provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Additonal Information

  • - Business description – A detailed description of the company’s operations and business divisions.
  • - Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • - Company history – Progression of key events associated with the company.
  • - Major products and services – A list of major products, services and brands of the company.
  • - Key competitors – A list of key competitors to the company.
  • - Key employees – A list of the key executives of the company.
  • - Executive biographies – A brief summary of the executives’ employment history.
  • - Key operational heads – A list of personnel heading key departments/functions.
  • - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • - Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
  • Highlights
  • Cipla Ltd (Cipla) is a pharmaceutical company, which manufactures and distributes branded medicines, generics and active pharmaceutical ingredients (APIs). It offers products for the treatment of various conditions such as cardiovascular and pediatric diseases, dermatological and cosmetological conditions, HIV/AIDS, diabetes, hepatitis, infectious diseases and critical care, malaria, cancer, neurological, ophthalmic, respiratory and urological conditions, osteoporosis and women's health. The company also operates in consumer healthcare and biosimilar businesses. Cipla manufactures metered-dose inhaler devices, spacers and related devices; and conducts R&D to develop new medicines and drug delivery systems. The company has operations in India, US, Canada, South Africa and major regulated and emerging markets among others. Cipla is headquartered in Mumbai, Maharashtra, India.
  • Cipla Ltd Key Recent Developments
  • Jun 21,2019: Cipla: Resignation of Mr. Peter Lankau as Independent Director of the Company
  • Jun 10,2019: Cipla: Closure Of USFDA inspection at Kurkumbh Manufacturing Facility
  • May 22,2019: Cipla reports Q4 and FY19 results
  • May 17,2019: USFDA post-approval inspection completed at Cipla's Indore manufacturing facility
  • Apr 22,2019: Cipla names Dr. Raju Mistry as Global Chief People Officer

Companies Mentioned

Alembic Limited
Dr. Reddy's Laboratories Ltd
Lupin Ltd
Aurobindo Pharma Ltd
Sun Pharmaceutical Industries Ltd
Biocon Ltd
Cadila Healthcare Ltd
Torrent Pharmaceuticals Ltd

Reasons to buy

You get detailed information about the company and its operations to identify potential customers and suppliers. The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Note: Some sections may be missing if data is unavailable for the company
Add to basket
  • Table of Contents
  • Table of Contents
  • List of Tables
  • List of Figures
  • Section 1 - About the Company
  • Cipla Ltd - Key Facts
  • Cipla Ltd - Key Employees
  • Cipla Ltd - Key Employee Biographies
  • Cipla Ltd - Major Products and Services
  • Cipla Ltd - History
  • Cipla Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Section 2 – Company Analysis
  • Company Overview
  • Cipla Ltd - Business Description
  • Business Segment: New Ventures
  • Overview
  • Performance
  • Business Segment: Pharmaceuticals
  • Overview
  • Performance
  • R&D Overview
  • Cipla Ltd - Corporate Strategy
  • Cipla Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Cipla Ltd - Strengths
  • Cipla Ltd - Weaknesses
  • Cipla Ltd - Opportunities
  • Cipla Ltd - Threats
  • Cipla Ltd - Key Competitors
  • Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Cipla Ltd, Recent Deals Summary
  • Section 5 – Company’s Recent Developments
  • Jun 21, 2019: Cipla: Resignation of Mr. Peter Lankau as Independent Director of the Company
  • Jun 10, 2019: Cipla: Closure Of USFDA inspection at Kurkumbh Manufacturing Facility
  • May 22, 2019: Cipla reports Q4 and FY19 results
  • May 17, 2019: USFDA post-approval inspection completed at Cipla's Indore manufacturing facility
  • Apr 22, 2019: Cipla names Dr. Raju Mistry as Global Chief People Officer
  • Apr 17, 2019: Pulmatrix and Cipla collaborate to develop asthma drug
  • Mar 31, 2019: Cipla: Product specific pre-approval (PAI) and Good Manufacturing Practices (GMP) inspection at its Kurkumbh plant
  • Feb 18, 2019: Cipla and Wellthy Therapeutics announce partnership to offer digital therapeutics for diabetes and cardiovascular diseases
  • Oct 04, 2018: Cipla:Inspection by the United States Food and Drug Administration (USFDA) at the Goa manufacturing facility
  • Sep 10, 2018: Understanding depression and related symptoms key to suicide prevention in SA
  • Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • List of Tables
  • Cipla Ltd, Key Facts
  • Cipla Ltd, Key Employees
  • Cipla Ltd, Key Employee Biographies
  • Cipla Ltd, Major Products and Services
  • Cipla Ltd, History
  • Cipla Ltd, Subsidiaries
  • Cipla Ltd, Key Competitors
  • Cipla Ltd, Ratios based on current share price
  • Cipla Ltd, Annual Ratios
  • Cipla Ltd, Annual Ratios (Cont...1)
  • Cipla Ltd, Annual Ratios (Cont...2)
  • Cipla Ltd, Interim Ratios
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Cipla Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • List of Figures
  • Cipla Ltd, Performance Chart (2015 - 2019)
  • Cipla Ltd, Ratio Charts
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Keywords
;